ESOP4 April 2026 at 07:13 am
Crescentis Capital Receives In-principle Approval from BSE for Employees' Stock Option Scheme 2025
AI Summary
Crescentis Capital Ltd. has received in-principle approval from BSE Limited for the issue of 13,00,000 equity shares of face value ₹10/- each under the 'Crescentis Capital Limited Employees' Stock Option Scheme 2025'. The approval was granted on April 02, 2026, and is subject to the company fulfilling certain conditions. These conditions include notifying the exchange upon allotment of shares, paying prescribed fees, receiving statutory approvals, complying with guidelines from SEBI, RBI, and MCA, and complying with all conditions of the Listing Agreement.
Key Highlights
- Crescentis Capital Ltd. received in-principle approval from BSE for Employees' Stock Option Scheme 2025
- 13,00,000 equity shares of face value ₹10/- each will be issued
- Approval granted vide letter bearing reference no. DCS/ESOP/IP/RD/006/2026-27 dated April 02, 2026
- Company must fulfill certain conditions to finalize the approval
- Conditions include notifying the exchange upon allotment of shares, paying prescribed fees, and receiving statutory approvals